FDA apwouve premye terapi jenetik pou trete adilt ki gen emofili B

FDA apwouve premye terapi jenetik pou trete adilt ki gen emofili B

FDA US Food & Drug Administration

Imaj

Please enable the javascript to submit this form

Sipòte pa sibvansyon edikasyon bay Bayer, BioMarin, CSL Behring, Freeline Therapeutics Limited, Pfizer Inc., Spark Therapeutics, ak uniQure, Inc.

Esansyèl SSL